<DOC>
	<DOCNO>NCT00672035</DOCNO>
	<brief_summary>The main purpose study evaluate body 's immune response LT patch different dos . The secondary purpose study evaluate safety LT patch different dos safety skin preparation system . Another secondary purpose compare safety body 's immune response LT patch place upper arm versus low back .</brief_summary>
	<brief_title>Prevention , Randomized , Double-Blinded , Placebo-Controlled , Parallel Assignment , Safety/Efficacy Study</brief_title>
	<detailed_description>This randomize , double-blind , placebo-controlled , dose ranging , multicenter study . Subjects assign one ten treatment group vaccinate accord study group designation . Treatments remain first second vaccination ( alternate leave right side ) .</detailed_description>
	<mesh_term>Diarrhea</mesh_term>
	<criteria>Subjects must meet follow criterion eligible participate study : Healthy adult male females 18 40 year age sign informed consent . Women postmenopausal surgically sterile must negative serum urine pregnancy test screening within 24 hour prior vaccination understanding ( informed consent process ) become pregnant duration study , must agree employ effective form birth control duration study . Acceptable form birth control : abstinence , hormonal contraceptive ( oral , injectable , implant , patch , ring ) , doublebarrier contraceptive ( condom , diaphragm spermicide ) , IUD . Subjects meet follow criterion eligible participation study : Laboratory abnormality . Abnormalities physical examination Known allergy component vaccine . Known disturbance coagulation . Known allergies adhesive . Participated unrelated research involve investigational product within 30 day plan date first vaccination . Ever receive investigational enterotoxigenic E. coli , LT , LT ( R192G ) NasalFlu , Berna Biotech , Ltd . Ever receive cholera toxin vaccine ( e.g . Orochol™ , Dukoral™ ) . Medical history acute chronic skin disease vaccination site ( ) . Active skin allergy . Recent regular use oral inject steroid medication . Use immunosuppressive systemic steroid medication include inhaled steroid within three month prior first vaccination . Comorbid condition treatment immunosuppressive , include cancer , diabetes , endstage renal disease , determine Investigator . Positive serology HIV1 , HIV2 , HBsAg , HCV . History severe atopy . Signs history acute skin infection , sunburn skin abnormality vaccination area ( ) include fungal infection , severe acne , history keloid formation , active contact dermatitis . Artificial tanning ( UV radiation ) duration study include screening period . Hirsute ( significant amount hair ) vaccination area ( ) . Visible tattoos mark ( tattoos/scars ) vaccination area ( ) would prevent appropriate dermatological monitoring vaccination site ( ) . Fever equal great 38.0°C ( ≥100.4°F ) time plan vaccination . Suspicion recent history alcohol substance abuse . Donated blood blood product plasma within past 30 day . Women pregnant breastfeeding . Employee investigational site . Medical history achlorhydria . History abdominal surgery ( exclude Csection , hysterectomy , cosmetic surgery , liposuction , appendectomy , cholecystectomy , ventral hernia repair , surgery pertain gastrointestinal problem ) history , recent acute gastrointestinal illness .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>LT</keyword>
	<keyword>Healthy Adults</keyword>
	<keyword>Dose Ranging</keyword>
	<keyword>Patch</keyword>
	<keyword>Vaccine</keyword>
</DOC>